William Hoffman, Director at Inari Medical, Inc. (NARI), sold 49,900 shares at $66.95 ($3.3M) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.27 | 3,229 | $214K | 6.4% |
| 2 | $66.27 | 3,229 | $214K | 6.4% |
| 3 | $66.40 | 7,099 | $471K | 14.2% |
| 4 | $66.40 | 7,099 | $471K | 14.2% |
| 5 | $66.95 | 6,671 | $447K | 13.4% |
| 6 | $66.95 | 6,671 |
| $447K |
| 13.4% |
| 7 | $67.05 | 7,901 | $530K | 15.9% |
| 8 | $67.05 | 7,901 | $530K | 15.9% |
| 9 | $67.58 | 100 | $7K | 0.2% |
| Total | $66.74 avg | 49,900 | $3.3M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |